Quick Answer
Burning Rock Biotech Ltd reported Total Revenue of $70.67 million for fiscal year 2024.
Burning Rock Biotech Ltd — Key Financials by Year
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | $70.67M -86.9% |
$537.43M -4.6% |
$563.24M +10.9% |
$507.86M +18.1% |
$429.90M +12.6% |
$381.68M +82.7% |
| Net Income | -$346.63M +47.0% |
-$653.69M +32.7% |
-$971.23M -21.9% |
-$796.70M -95.6% |
-$407.24M -140.7% |
-$169.16M +4.7% |
| Total Assets | $885.30M -14.9% |
$1.04B -34.5% |
$1.59B -30.3% |
$2.28B -14.4% |
$2.66B +214.2% |
$847.56M |
| Cash and Equivalents | $519.85M -15.5% |
$615.10M -32.1% |
$905.45M -36.7% |
$1.43B -24.5% |
$1.90B +1911.3% |
$94.23M +1.0% |
| Stockholders Equity | $79.57M -89.6% |
$768.41M -33.7% |
$1.16B -37.2% |
$1.85B -23.8% |
$2.42B +371.6% |
-$891.49M -47.7% |
| R&D Expense | $232.29M -33.1% |
$347.02M -17.7% |
$421.87M +14.7% |
$367.86M +39.4% |
$263.94M +68.2% |
$156.94M +49.0% |
| Operating Income | -$357.56M +46.6% |
-$669.32M +31.7% |
-$980.41M -23.0% |
-$797.06M -93.3% |
-$412.40M -143.9% |
-$169.09M -4.8% |
| Gross Profit | $49.65M -86.3% |
$363.23M -4.4% |
$380.04M +4.4% |
$364.15M +16.0% |
$313.92M +14.8% |
$273.33M +102.4% |
| Shares Outstanding | — | — | — | — | 0 -100.0% |
25.03M |
- Burning Rock Biotech Ltd reported Total Revenue of $70.67 million for fiscal year 2024.
- Burning Rock Biotech Ltd showed a decrease of -86.9% in Total Revenue compared to the prior fiscal year.
- Burning Rock Biotech Ltd reported Net Income of -$346.63 million for fiscal year 2024.
- Burning Rock Biotech Ltd showed an increase of +47.0% in Net Income compared to the prior fiscal year.
- Burning Rock Biotech Ltd reported Total Assets of $885.30 million for fiscal year 2024.
- Burning Rock Biotech Ltd showed a decrease of -14.9% in Total Assets compared to the prior fiscal year.
- Burning Rock Biotech Ltd reported Cash and Equivalents of $519.85 million for fiscal year 2024.
- Burning Rock Biotech Ltd showed a decrease of -15.5% in Cash and Equivalents compared to the prior fiscal year.
- Burning Rock Biotech Ltd reported Stockholders Equity of $79.57 million for fiscal year 2024.
- Burning Rock Biotech Ltd showed a decrease of -89.6% in Stockholders Equity compared to the prior fiscal year.
- Burning Rock Biotech Ltd reported R&D Expense of $232.29 million for fiscal year 2024.
- Burning Rock Biotech Ltd showed a decrease of -33.1% in R&D Expense compared to the prior fiscal year.
- Burning Rock Biotech Ltd reported Operating Income of -$357.56 million for fiscal year 2024.
- Burning Rock Biotech Ltd showed an increase of +46.6% in Operating Income compared to the prior fiscal year.
- Burning Rock Biotech Ltd reported Gross Profit of $49.65 million for fiscal year 2024.
- Burning Rock Biotech Ltd showed a decrease of -86.3% in Gross Profit compared to the prior fiscal year.
- Burning Rock Biotech Ltd reported Shares Outstanding of 0 shares for fiscal year 2020.
- Burning Rock Biotech Ltd showed a decrease of -100.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: